-
The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams. Views are subject to revision over time.
Past performance and current analysis do not guarantee future results.
*Based on net interest income from 48 European banks.
†Percent change in consensus earnings per share (EPS) estimates for calendar year 2023 on April 19, 2023, vs. estimates three months earlier.
Left display through April 18, 2023; right display as of April 19, 2023
Source: Autonomous Research, FactSet, MSCI and AllianceBernstein (AB)
Past performance and current analysis do not guarantee future results.
Through April 18, 2023
Source: Bloomberg, STOXX and AB
The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams. Views are subject to revision over time.
Andrew Birse was appointed Chief Investment Officer of European Value Equities in November 2022 after serving as portfolio manager of European Value Equities since March 2016. He has also served as Chief Investment Officer of International Small Cap Equities since 2021 and has managed the International Small Cap and European Small Cap Equities services since inception in 2014 and 2017, respectively. Prior to joining the firm as a research analyst in 2010, Birse spent seven years in the Corporate Finance Group at McKinsey & Company, working in the firm's London, Sydney and Auckland offices. He holds a BCom (honors) in finance and a BA in history and economics from the University of Auckland, and an MSc in economics and philosophy from the London School of Economics. Location: New Zealand
Jane Bleeg was appointed Portfolio Manager of European Value Equities in November 2022. Prior to this she was a senior research analyst responsible for European healthcare and consumer discretionary companies for the Value Equities Group. Before joining the firm in 2016, Bleeg was an engagement manager in the life sciences practice of L.E.K. Consulting, a hedge-fund analyst at Great Point Partners and an investment banking analyst in the Healthcare Investment Banking Group at Piper Jaffray & Co. She holds a BBA (magna cum laude) in finance from the University of Notre Dame and an MBA (with distinction) from Saïd Business School at the University of Oxford. Location: London
This information is for exclusive use of the wholesale person to whom it is provided and is not to be relied upon by any other person. It is not intended for retail or public use and may not be further distributed without prior written consent of ABAL.
This webpage has been prepared by AllianceBernstein Australia Limited (“ABAL”)—ABN 53 095 022 718, AFSL 230 698. Information in this webpage is only intended for persons that qualify as “wholesale clients,” as defined by the Financial Markets Conduct Act 2013’, and is not to be construed as advice. This webpage is provided solely for informational purposes and is not an offer to buy or sell securities. The information, forecasts and opinions set forth in this webpage have not been prepared for any recipient’s specific investment objectives, financial situation or particular needs. Neither this webpage nor the information contained in it are intended to take the place of professional advice.
You should not take action on specific issues based on the information contained in this webpage without first obtaining professional advice. Past performance does not guarantee future results. Projections, although based on current information, may not be realized. Information, forecasts and opinions can change without notice and ABAL does not guarantee the accuracy of the information at any particular time. Although care has been exercised in compiling the information contained in this webpage, ABAL does not warrant that this webpage is free from errors, inaccuracies or omissions. ABAL disclaims any liability for damage or loss arising from reliance upon any matter contained in this webpage except for statutory liability which cannot be excluded.
No reproduction of the materials on this webpage may be made without the express written permission of ABAL. This information is provided for persons in Australia only and is not being provided for the use of any person who is in any other country.